Sofinnova Investments, Inc. Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$1.6T
Holdings
57
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics Inc | 1,381,149 | $233.5B | 14.73% | |
| 2 | NTRANatera Inc | 3,100,560 | $137.2B | 8.65% | |
| 3 | AZNAstraZeneca PLC | 1,362,836 | $92.3B | 5.82% | |
| 4 | MRKMerck & Co Inc | 728,404 | $75.0B | 4.73% | |
| 5 | ASNDAscendis Pharma A/S | 754,032 | $70.6B | 4.45% | |
| 6 | —RayzeBio Inc | 2,419,528 | $53.7B | 3.39% | |
| 7 | DC4Dexcom Inc | 550,197 | $51.3B | 3.24% | |
| 8 | AVTEAerovate Therapeutics Inc | 3,758,686 | $51.0B | 3.22% | |
| 9 | ISRGIntuitive Surgical Inc | 173,277 | $50.6B | 3.19% | |
| 10 | VERAVera Therapeutics Inc | 3,467,156 | $47.5B | 3.00% | |
| 11 | CYTKCytokinetics Inc | 1,560,164 | $46.0B | 2.90% | Put |
| 12 | ELANElanco Animal Health Inc | 3,610,024 | $40.6B | 2.56% | |
| 13 | IWMIShares TR | 225,000 | $39.8B | 2.51% | Put |
| 14 | ARGXargenx SE | 78,186 | $38.4B | 2.42% | |
| 15 | EX9Exelixis Inc | 1,743,364 | $38.1B | 2.40% | Put |
| 16 | IMTXImmatics NV | 3,251,509 | $37.7B | 2.38% | |
| 17 | SNYSanofi | 695,375 | $37.3B | 2.35% | |
| 18 | KVUEKenvue Inc | 1,802,084 | $36.2B | 2.28% | |
| 19 | IDXXIDEXX Laboratories Inc | 77,881 | $34.1B | 2.15% | |
| 20 | IMGNEURImmunoGen Inc | 2,045,202 | $32.5B | 2.05% | |
| 21 | SNDXSyndax Pharmaceuticals Inc | 1,991,817 | $28.9B | 1.82% | Put |
| 22 | IDYAIDEAYA Biosciences Inc | 1,037,187 | $28.0B | 1.77% | |
| 23 | ZNTLZentalis Pharmaceuticals Inc | 1,211,641 | $24.3B | 1.53% | |
| 24 | SPYSPDR S&P 500 ETF Trust | 50,000 | $21.4B | 1.35% | Put |
| 25 | REPLReplimune Group Inc | 1,066,944 | $18.3B | 1.15% | Put |
| 26 | INZYInozyme Pharma Inc | 4,280,308 | $18.0B | 1.13% | |
| 27 | QQQInvesco QQQ TR | 50,000 | $17.9B | 1.13% | |
| 28 | TCE2Celldex Therapeutics Inc | 624,259 | $17.2B | 1.08% | Put |
| 29 | AGENEURAgenus Inc | 14,964,748 | $16.9B | 1.07% | Call |
| 30 | MLTXMoonLake Immunotherapeutics | 292,805 | $16.7B | 1.05% | |
| 31 | —Shockwave Med Inc | 81,373 | $16.2B | 1.02% | |
| 32 | ALKSAlkermes PLC | 537,464 | $15.1B | 0.95% | |
| 33 | INBXUSDInhibrx Inc | 743,294 | $13.6B | 0.86% | |
| 34 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $12.0B | 0.75% | |
| 35 | MRNS*Marinus Pharmaceuticals Inc | 1,306,206 | $10.5B | 0.66% | Call |
| 36 | GPCRStructure Therapeutics Inc | 202,119 | $10.2B | 0.64% | |
| 37 | CRSPCRISPR Therapeutics AG | 200,000 | $9.1B | 0.57% | Put |
| 38 | GONGeron Corp | 3,702,546 | $7.8B | 0.50% | |
| 39 | SRPTSarepta Therapeutics Inc | 51,100 | $6.2B | 0.39% | Call |
| 40 | DYNDyne Therapeutics Inc | 685,133 | $6.1B | 0.39% | |
| 41 | AXSMAxsome Therapeutics Inc | 80,368 | $5.6B | 0.35% | |
| 42 | IMVTImmunovant Inc | 139,885 | $5.4B | 0.34% | |
| 43 | NXTCNextcure Inc | 2,671,856 | $3.4B | 0.22% | |
| 44 | —Nucana PLC | 5,599,999 | $3.4B | 0.22% | |
| 45 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $2.9B | 0.18% | |
| 46 | —Nucana PLC | 2,400,000 | $1.5B | 0.09% | |
| 47 | IMTXImmatics NV | 318,896 | $1.1B | 0.07% | |
| 48 | SYKStryker Corporation | 3,279 | $896.1M | 0.06% | |
| 49 | PDSBPDS Biotechnology Corp | 142,635 | $720.3M | 0.05% | |
| 50 | YB4PSavara Inc | 157,908 | $596.9M | 0.04% | |
| 51 | GRTXGalera Therapeutics Inc | 3,083,712 | $540.0M | 0.03% | |
| 52 | —Ikena Oncology Inc | 115,712 | $501.0M | 0.03% | |
| 53 | —Fusion Pharmaceuticals Inc | 117,099 | $304.5M | 0.02% | |
| 54 | MIRMMirum Pharmaceuticals Inc | 9,089 | $287.2M | 0.02% | |
| 55 | CBAYUSDCymaBay Therapeutics Inc | 11,040 | $164.6M | 0.01% | Put |
| 56 | SPRBSpruce Biosciences Inc | 58,029 | $131.1M | 0.01% | |
| 57 | SYBXSynlogic Inc | 38,331 | $107.7M | 0.01% |